Generic medicines, which are clinically equivalent to their branded counterparts, are a cornerstone in efforts to improve healthcare affordability and broaden patient access to essential treatments.
The assessment of therapeutic equivalence carries important consequences for how a medicinal product is managed, particularly concerning the choice of the prescribing physician and the possibility of ...